BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kim HB, Park SG, Hong R, Kang SH, Na YS. Acute myelomonocytic leukemia during pembrolizumab treatment for non-small cell lung cancer: A case report. World J Clin Cases 2020; 8(13): 2833-2840 [PMID: 32742992 DOI: 10.12998/wjcc.v8.i13.2833]
URL: https://www.wjgnet.com/2307-8960/full/v8/i13/2833.htm
Number Citing Articles
1
Mick J. M. van Eijs, Lotte E. van der Wagen, Rogier Mous, Roos J. Leguit, Lisette van de Corput, Anne S. R. van Lindert, Britt B. M. Suelmann, Anna M. Kamphuis, Stefan Nierkens, Karijn P. M. Suijkerbuijk. Hematologic malignancies following immune checkpoint inhibition for solid tumorsCancer Immunology, Immunotherapy 2023; 72(1): 249 doi: 10.1007/s00262-022-03230-4
2
Kousei Nakatsuru, Kazuya Tsubouchi, Minori Hirahata, Tadayuki Nakashima, Yuriko Takahata, Yuki Okamatsu, Yoshimasa Shiraishi, Isamu Okamoto, Taishi Harada. Acute myeloid leukemia and myelodysplastic syndrome associated with a combination of immune checkpoint inhibitor and platinum‐based chemotherapyThoracic Cancer 2023; 14(22): 2225 doi: 10.1111/1759-7714.15005
3
Carboplatin/pembrolizumabReactions Weekly 2020; 1818(1): 74 doi: 10.1007/s40278-020-82354-4